berberine has been researched along with evodiamine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 5 (31.25) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Peng, JY; Qi, Y; Wang, XN; Xu, LN; Xu, YW; Yin, LH | 1 |
| Du, M; Jin, R; Kang, C; Li, J; Li, M; Liu, S | 1 |
| Davies, GE; Fahmy, H; Hu, Y; Zjawiony, JK | 1 |
| Chang, CS; Chao, DC; Ho, TY; Hsiang, CY; Huang, HC; Kao, ST; Liang, JA; Lin, LJ; Wu, SL | 1 |
| Davies, GE; Ehli, EA; Hu, Y; Hudziak, JJ | 1 |
| Liu, Y; Shi, HL; Wu, XJ; Xie, JQ | 1 |
| Jin, DY; Lou, WH; Rong, YF; Wu, W; Xu, XF; Zhang, L | 1 |
| Gong, XL; Huang, C; Liu, H; Wen, B; Wu, LY | 1 |
| Chiang, SY; Chou, ST; Ho, TY; Hsiang, CY; Hsieh, CL; Huang, HF; Lai, MT; Lo, HY | 1 |
| Liu, L; Ni, H; Ren, F; Ren, J; Shen, T; Wei, H; Wei, J; Xu, S; Zhou, X | 1 |
| Chen, TY; Feng, Y; Li, NX; Wu, M; Yang, Q; Yin, HL | 1 |
| Guan, X; Vong, CT; Wang, Y; Xiao, J; Zhao, J; Zheng, X; Zhong, Z | 1 |
| Choi, Y; Lin, H; Lin, L; Michniak-Kohn, B | 1 |
| Huang, C; Huang, WX; Liang, BJ; Liu, HS; Shao, YW; Shen, WZ; Wang, XL; Xiang, KM; Zhang, FJ | 1 |
| Cui, YL; Qiao, T; Qiu, C; Wang, Y; Xu, D | 1 |
| Dai, Y; Shen, T; Zhou, J; Zhu, W | 1 |
16 other study(ies) available for berberine and evodiamine
| Article | Year |
|---|---|
Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine.
Topics: Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Phytotherapy; Plant Extracts; Quinazolines; Tumor Necrosis Factor-alpha | 2008 |
[Study on vitro release and transdermal behaviors of Yulian cataplasm].
Topics: Animals; Berberine; Berberine Alkaloids; Drugs, Chinese Herbal; Indole Alkaloids; Mice; Plant Extracts; Quinazolines; Skin; Skin Absorption | 2009 |
Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation.
Topics: Adipocytes; Adipose Tissue, White; Anti-Obesity Agents; Berberine; Cell Differentiation; Cell Line; GATA2 Transcription Factor; GATA3 Transcription Factor; Gene Expression Regulation; Humans; Plant Extracts; Quinazolines; RNA, Messenger; Up-Regulation | 2010 |
Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Coptis; Drugs, Chinese Herbal; Evodia; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Plant Extracts; Quinazolines; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2011 |
Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region.
Topics: Alleles; Animals; Berberine; Cell Line; Gene Expression; Plant Extracts; Polymorphism, Genetic; Promoter Regions, Genetic; Quinazolines; Rats; Serotonergic Neurons; Serotonin Plasma Membrane Transport Proteins | 2012 |
Berberine counteracts enhanced IL-8 expression of AGS cells induced by evodiamine.
Topics: Antineoplastic Agents, Phytogenic; Berberine; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Chemokines; Chemokines, CXC; Chromones; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-8; Morpholines; Pyridines; Quinazolines; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured | 2013 |
SN38 increases IL-8 expression through the MAPK pathways in HCT8 cells.
Topics: Berberine; Camptothecin; Cell Line, Tumor; Cell Survival; Fluorouracil; Humans; Interleukin-8; Irinotecan; Janus Kinase 2; MAP Kinase Signaling System; Phosphorylation; Quinazolines; Up-Regulation | 2017 |
Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1.
Topics: Animals; Animals, Newborn; Berberine; Cell Transformation, Neoplastic; Colon; Colonic Neoplasms; DNA (Cytosine-5-)-Methyltransferases; Gene Expression Regulation, Neoplastic; Immunoenzyme Techniques; MicroRNAs; Promoter Regions, Genetic; Quinazolines; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta1 | 2017 |
Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Berberine; Carcinoma, Hepatocellular; Coptis; Drugs, Chinese Herbal; Evodia; Female; Hep G2 Cells; Heterografts; Humans; Medicine, Chinese Traditional; Mice, Inbred ICR; Phytotherapy; Quinazolines | 2017 |
Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
Topics: Administration, Oral; Animals; Apolipoprotein B-48; Berberine; Body Weight; Cholesterol, LDL; Coptis; Diet, High-Fat; Drug Combinations; Evodia; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lipid Metabolism; Liver; Male; Membrane Transport Proteins; Quinazolines; Rats; Rats, Sprague-Dawley; Sitosterols; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2; Triglycerides | 2017 |
Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
Topics: Animals; Antineoplastic Agents; Berberine; Cell Line, Tumor; Cell Movement; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Mice; Nanoparticles; Quinazolines; Silicon Dioxide; Temperature; Xenograft Model Antitumor Assays | 2019 |
Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Caco-2 Cells; Cardiotoxicity; Colon; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Epithelial Cells; HT29 Cells; Humans; Intestinal Mucosa; Myocytes, Cardiac; Quinazolines; Rats | 2020 |
Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma.
Topics: Animals; Berberine; Drug Delivery Systems; Drug Development; Female; Humans; Liposomes; Melanoma, Experimental; Mice; Middle Aged; Plant Extracts; Quinazolines; Skin Absorption | 2020 |
Combination of Evodiamine with Berberine Reveals a Regulatory Effect on the Phenotypic Transition of Colon Epithelial Cells Induced by CCD-18Co.
Topics: Actins; Berberine; Biomarkers; Cadherins; Cell Line; Cell Movement; Colon; Epithelial Cells; Epithelial-Mesenchymal Transition; Fluorescence; Humans; Phenotype; Quinazolines; Signal Transduction; Smad Proteins; Transcription Factors; Transforming Growth Factor beta1; Wound Healing | 2020 |
Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder.
Topics: Administration, Intranasal; Animals; Berberine; Depressive Disorder; Hydrogels; Mice; Quinazolines; Rats; Temperature | 2021 |
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats.
Topics: Animals; Berberine; Diet, High-Fat; Gastrointestinal Microbiome; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Quinazolines; Rats | 2022 |